Concepedia

Talha Munir

TM

Statistics

Publications

10

Citations

774

H-Index

10

Active since

2019

Affiliations

St James's University Hospital(Current)

Leeds Teaching Hospitals NHS Trust

Copenhagen University Hospital

Universitat Autònoma de Barcelona

Universitair Ziekenhuis Leuven

Talha Munir is an author at St James's University Hospital specializing in medicine, hematologic oncology, and oncology.

ORCID

Publications per year

2019–2025

10

Publications

10

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

Talha Munir, Jennifer R. Brown, Susan O’Brien et al. · American Journal of Hematology · 2019 · 473 citations · Full text

, , +14

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

Michael Wang, Wojciech Jurczak, Pier Luigi Zinzani et al. · Journal of Clinical Oncology · 2023 · 106 citations · Full text

, , +16

Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

Talha Munir, Carol Moreno, Carolyn Owen et al. · Journal of Clinical Oncology · 2023 · 44 citations · Full text

, , +17

Real‐world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria

Morag Griffin, Richard Kelly, Isabelle Brindel et al. · American Journal of Hematology · 2024 · 39 citations · Full text

, , +13

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Jeff P. Sharman, Talha Munir, Sebastian Grosicki et al. · Journal of Clinical Oncology · 2025 · 31 citations · Full text

, , +15

1–5 of 10